Page last updated: 2024-10-29

ketamine and Maxillary Neoplasms

ketamine has been researched along with Maxillary Neoplasms in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rewari, V1
Sabapathy, S1
Ramachandran, R1
Nakamura, A1

Other Studies

2 other studies available for ketamine and Maxillary Neoplasms

ArticleYear
Giant maxillary hemangioma in a child--Ketamine to the rescue.
    Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists, 2015, Volume: 53, Issue:3

    Topics: Child; Hemangioma; Humans; Intubation, Intratracheal; Ketamine; Maxillary Neoplasms

2015
[Clinical experience using Ketalar in the surgery of sinusitis].
    Jibi inkoka Otolaryngology, 1971, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Analgesics; Anesthesia, General; Cyclohexanes; Female; Hematoma; Hemorrhage; Huma

1971